AssetID: 53744101
Headline: New Analysis Suggests Long-Term Effectiveness for Wegovy Users
Caption: NBC reports that patients taking Novo Nordisk's obesity treatment maintain an average of 10% weight loss over four years. The news potentially boosts the drugmaker's push for Wegovy to be covered by insurers and governments.
Keywords: New,Patients,Drugmaker,Wegovy,Covered,Insurers,Governments,Obesity,Treatment,Average,Longest,Majority,Increase,Start,Company,Analysis
PersonInImage: